Market Research Logo

Global Pruritus Therapeutic Market 2017-2021

Global Pruritus Therapeutic Market 2017-2021

About Global Pruritus Therapeutic

Pruritus is defined as the unpleasant skin sensation that frequently provokes scratching. Various systemic diseases are the major cause of pruritus. The intensity of sensation ranges from mild to severe. Various diseases cause changes/imbalance of biochemical factors, which trigger skin sensation and lead to pruritus. The market is segmented based on these disease conditions, which are responsible for pruritus.

Technavio’s analysts forecast the global pruritus therapeutic market to grow at a CAGR of 4.95% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global pruritus therapeutic market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Pruritus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
Other prominent vendors
  • Abbott
  • Ajanta Pharma
  • Almirall
  • Astellas Pharma
  • Bristol-Myers Squibb
  • CARA Therapeutic
  • Cipla
  • Eisai
  • Eli Lilly
  • Galderma
  • Glenmark
  • Heron Therapeutic
  • IPCA
  • Lupin
  • Merck
  • Novartis
  • Sun Pharma
  • Takeda Pharmaceutical
Market driver
  • Drug-induced pruritus
  • For a full, detailed list, view our report
Market challenge
  • Poor patient adherence due to inadequate information on drug usage
  • For a full, detailed list, view our report
Market trend
  • Incorporation of novel technology for product development
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Pruritus Therapeutic Market 2017-2021

Technavio recognizes the following companies as the key players in the global pruritus therapeutic market: Allergan, GlaxoSmithKline, Pfizer, and Sanofi.

Other Prominent Vendors in the market are: Abbott, Ajanta Pharma, Almirall, Astellas Pharma, Bristol-Myers Squibb, CARA Therapeutic, Cipla, Eisai, Eli Lilly, Galderma, Glenmark, Heron Therapeutic, IPCA, Lupin, Merck, Novartis, Sun Pharma, and Takeda Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is incorporation of novel technology for product development. The incorporation of novel technologies in the development of products for the treatment of fungal infections including pruritus is one of the upcoming trends in the market. For instance, Merz Pharmaceuticals' ONMEL (now acquired by Sebela), which contains the active ingredient itraconazole, was developed by using the Meltrex technology of Abbott.”

According to the report, one driver in the market is drug-induced pruritus. Pruritus is one of the major dermatological side effects of a variety of drugs. The reason may be due to a direct effect on skin structures or indirectly through nephrotoxicity or iatrogenic hepatotoxicity. Subclinical sensitivity to any drug can also lead to pruritus. Drug-induced pruritus can be both acute type or chronic type. The acute pruritus is observed within first six weeks of drug treatment, and it is cured as soon as the drug therapy is stopped. For instance, the pruritus induced due to antimalarial drugs cause acute type, which shows itching for 1-3 days.

Further, the report states that one challenge in the market is poor patient adherence due to inadequate information on drug usage. In the generic-heavy pruritus drugs market, nearly half of the treatment failures happen because of inadequate patient compliance. It has been observed that the patient outcome at even specialist centers is not positive as the treatment is not administered properly. The primary reason behind the treatment failure is the inadequate time spent by physicians in educating the individuals about various pruritus causing diseases and medications for these conditions.

Companies Mentioned

Allergan, GlaxoSmithKline, Pfizer, and Sanofi.

Other Prominent Vendors in the market are: Abbott, Ajanta Pharma, Almirall, Astellas Pharma, Bristol-Myers Squibb, CARA Therapeutic, Cipla, Eisai, Eli Lilly, Galderma, Glenmark, Heron Therapeutic, IPCA, Lupin, Merck, Novartis, Sun Pharma, and Takeda Pharmaceutical.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Table Types of pruritus based on causative disease
    • Table Chemical substances that trigger pruritus
  • Market overview
    • Table Major diseases that cause pruritus
    • Table Major drug classes that induce pruritus
    • Table Global pruritus therapeutic market drivers
    • Table Global pruritus therapeutic market 2016-2021 ($ millions)
    • Table Opportunity analysis in global pruritus therapeutic market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline molecules based on vendors
    • Table Key clinical trials
  • Market segmentation by disease type
    • Table Segmentation of global pruritus therapeutic market by disease type 2016
    • Table Segmentation of global pruritus therapeutic market share by disease type 2016
    • Renal pruritus
      • Table Global renal pruritus therapeutic market 2016-2021 ($ millions)
    • Cholestatic pruritus
      • Table Global cholestatic pruritus therapeutic market 2016-2021 ($ millions)
    • Hematologic pruritus
      • Table Global hematologic pruritus therapeutic market 2016-2021 ($ millions)
    • Endocrine pruritus
      • Table Global endocrine pruritus therapeutic market 2016-2021 ($ millions)
    • Oncological pruritus
      • Table Global oncological pruritus therapeutic market 2016-2021 ($ millions)
  • Market segmentation by route of administration (ROA)
    • Table Various ROAs applied for pruritic drugs 2016
  • Geographical segmentation
    • Table Segmentation of global pruritus therapeutic market by geography 2016 and 2021
    • Table Global pruritus therapeutic market revenue by geography 2016-2021 ($ millions)
    • Pruritus therapeutic market in Americas
      • Table Market scenario in Americas
      • Table Pruritus therapeutic market in Americas 2016-2021 ($ millions)
    • Pruritus therapeutic market in EMEA
      • Table Market scenario in EMEA
      • Table Pruritus therapeutic market in EMEA 2016-2021 ($ millions)
    • Pruritus therapeutic market in APAC
      • Table Market scenario in APAC
      • Table Pruritus therapeutic market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Prevalence of pruritus in various disease conditions
      • Table Various drugs responsible for inducing pruritus
      • Table Phase III drugs for management of pruritus
    • Market challenges
      • Table Global sales of Allegra 2008 and 2016 ($ millions)
  • Market trends
    • Identification of new T-cell subsets (Th17 and Th22)
      • Table Role of newer T-cell subsets in dermatological diseases
    • Incorporation of novel technology for product development
    • Inorganic growth strategies
      • Table Inorganic growth strategies
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global pruritus therapeutic market 2016
      • Table Market penetration of various global pruritus therapeutic manufacturers 2016
      • Table Strategic success factors of companies in global pruritus therapeutic market
  • Key vendor analysis
    • Allergan
      • Table Allergan: Key highlights
      • Table Allergan: Strength assessment
      • Table Allergan: Strategy assessment
      • Table Allergan: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: strategy assessment
      • Table Sanofi: opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report